Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo
Open Access
- 31 July 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (1) , 67-75
- https://doi.org/10.1016/j.ymthe.2004.04.004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transferExperimental Neurology, 2003
- Evaluation of Infection Parameters in the Production of Replication‐Defective HSV‐1 Viral VectorsBiotechnology Progress, 2002
- Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectorsGene Therapy, 2001
- Binding of GDNF and Neurturin to Human GDNF Family Receptor α 1 and 2Journal of Biological Chemistry, 2000
- Replicating herpes simplex virus vectors for cancer gene therapyExpert Opinion on Pharmacotherapy, 2000
- Gene Transfer to Neurons Using Herpes Simplex Virus-Based VectorsAnnual Review of Neuroscience, 1996
- Unilateral dopamine lesions in neonatal, weanling and adult rats: comparison of rotation and reaching deficitsBehavioural Brain Research, 1992
- In vitro Promoter Activity Associated with the Latency-associated Transcript Gene of Herpes Simplex Virus Type 1Journal of General Virology, 1989
- Latent Herpes Simplex Virus in Human Trigeminal GangliaNew England Journal of Medicine, 1987
- Detection of HSV-1 genome in central nervous system of latently infected miceNature, 1983